Pfizer chief executive Ian Read said Tuesday that he sees a “huge sense of urgency” from the Trump administration to eliminate the existing safe harbor for drug rebates.
Pfizer Beats Earnings And Addresses Drug Pricing, Rebates
Pfizer chief executive Ian Read said Tuesday that he sees a “huge sense of urgency” from the Trump administration to eliminate the existing safe harbor for drug rebates.